Treating pediatric depression in primary care: Coping with the patients' blue mood and the FDA's black box

Journal of Pediatrics

Volumn 148, Issue 5, 2006, Pages

  Rappaport, Nancy ^a   Bostic, Jeff Q ^a   Prince, Jefferson B ^a   Jellinek, Michael ^a  

^a CAMBRIDGE HEALTH ALLIANCE   (United States)

Author keywords

adolescents; children; major depression; SSRI

Indexed keywords

ANTIDEPRESSANT AGENT; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

AGITATION; AKATHISIA; ANXIETY; APATHY; ARTICLE; BEHAVIOR THERAPY; CHILD PSYCHIATRY; CLINICAL FEATURE; CLINICAL TRIAL; CLONUS; COGNITIVE THERAPY; CONFUSION; COPING BEHAVIOR; DEPRESSION; DIAPHORESIS; DIZZINESS; DRUG MONITORING; FEAR; FEVER; FOOD AND DRUG ADMINISTRATION; HUMAN; HYPERREFLEXIA; HYPERTHERMIA; INSOMNIA; IRRITABILITY; LETHARGY; MANIA; MUSCLE HYPERTONIA; NAUSEA; PARESTHESIA; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PSYCHOTHERAPY; RESTLESSNESS; RISK FACTOR; SHIVERING; SIDE EFFECT; SUICIDE ATTEMPT; TREMOR; VIVID DREAM; ADAPTIVE BEHAVIOR; ADOLESCENT; CHILD; DRUG LEGISLATION; PRESCHOOL CHILD; PRIMARY HEALTH CARE; PSYCHOLOGICAL ASPECT; REVIEW; UNITED STATES;

ADAPTATION, PSYCHOLOGICAL; ADOLESCENT; ANTIDEPRESSIVE AGENTS; CHILD; CHILD, PRESCHOOL; COGNITIVE THERAPY; DEPRESSIVE DISORDER; DRUG MONITORING; HUMANS; LEGISLATION, DRUG; PRIMARY HEALTH CARE; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 33646918283     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2006.04.023     Document Type: Article

References (24)

1. Rapaport N, Prince JB, Bostic J. Lost in the Black Box: Juvenile depression, suicide, and the FDA's black box. J Pediatr 147:719-20.
2. Dooren J.C. Warning labels seem to curb youths' antidepressant use. The Wall Street Journal (2005) Feb 2; Sect. D (col. 1)
3. Goodwin R., Gould M.S., Blanco C., and Olfson M. Prescription of psychotropic medications to youths in office-based practice. Psychiatr Serv 52 (2001) 1081-1087
4. Rushton J.L., Clark S.J., and Freed G.L. Pediatrician and family physician prescription of selective serotonin reuptake inhibitors. Pediatrics 105 (2000) 957-962
5. Klein D.N., Dougherty L.R., and Olino T. Toward guidelines for evidence based assessment of depression in children and adolescents. J Clin Child Adolesc Psychol 34 (2005) 412-432
6. Carlson G.A., and Kashani J.H. Phenomenology of major depression from childhood through adulthood. analysis of three studies. Am J Psychiatry 45 (1988) 1222-1225
7. Rao U., Ryan N.D., Birmaher B., Dahl R.E., Williamson D.E., Kaufman J., et al. Unipolar depression in adolescents clinical outcome in adulthood. J Am Acad Child Adolesc Psychiatry 34 (1995) 579-590
8. Chambers W.J., Puig-Antich J., Tabrizi M.A., and Davies M. Psychotic symptoms in prepubertal major depressive disorder. Arch Gen Psychiatry 39 (1982) 921-927
9. Geller B., Zimmerman B., Williams M., Bolhofner K., and Craney J.L. Bipolar disorder at prospective follow-up of adults who had prepubertal major depressive disorder. Am J Psychiatry 158 (2001) 125-127
10. Martin A., Young C., Leckman J.F., Mukonoweshuro C., Rosenheck R., and Leslie D. Age effects on antidepressant-induced manic conversion. Arch Pediatr Adolesc Med 158 (2004) 773-780
11. Harris J. The increased diagnosis of "Juvenile Bipolar Disorder". what are we treating?. Psychiatr Serv 56 (2005) 529-531
12. Gould M.S., Fisher P., Parides M., Flory M., and Shaffer D. Psychosocial risk factors of child and adolescent completed suicide. Arch Gen Psychiatry 53 (1996) 1155-1162
13. Hayward C., Killen J.D., Kraemer H.C., and Barr Taylor C. Predictors of panic attacks in adolescents. J Am Acad Child Adolesc Psychiatry 39 (2000) 207-214
14. Brent D., and Birmaher B. Adolescent depression. N Engl J Med 347 (2002) 667-671
15. March J., Silva S., Petrycki S., Curry J., Wells K., Fairbank J., et al., Treatment for adolescents with depression study (TADS) team coordinating center. Fluoxetine, cognitive behavioral therapy, and their combination for adolescents with depression. JAMA 292 (2004) 807-820
16. Geller, DA, Biederman J., Stewart S.E., Mullin B., Martin A., Spencer T., and Faraone S.V. Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder. Am J Psychiatry 160 (2003) 1919-1928
17. Wong I.C.K., Besag F.M.C., Santosh P.J., and Murray M.L. Use of selective serotonin reuptake inhibitors in children and adolescents. Drug Saf 27 (2004) 991-1000
18. Emslie G.J., Rush J., Weinberg W.A., Kovatch R.A., Hughes C.W., Carmody T., et al. A double blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry 54 (1997) 1031-1037
19. Zimmerman M., Mattia J.I., and Posternak M.A. Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice?. Am J Psychiatry 159 (2002) 469-473
20. United States Food and Drug Administration. [MG-template.pdf]. Antidepressant use in children, adolescents, and adults (2004). http://www.fda.gov/cder/drugs/antidepressants/MG-template.pdf http://www.fda.gov/cder/drugs/antidepressants/MG-template.pdf
21. Walkup J., and Labellarte M. Complications of SSRI treatment. J Child Adolesc Psychopharmacol 11 (2001) 1-4
22. Schark A. Selective serotonin reuptake inhibitor-induced sexual dysfunction in adolescents. a review. J Am Acad Child Adolesc Psychiatry 43 (2004) 1071-1079
23. Emslie G.J., Mayes T.L., and Hughes C.W. Update in the pharmacologic treatment of childhood depression. Psychiatr Clin North Am 23 (2000) 813-835
24. American Academy of Child and Adolescent Psychiatry (AACAP). Practice parameters for the assessment and treatment of children and adolescents with depressive disorder. J Am Acad Child Adolesc Psychiatry 37 10 Suppl (1998) 63S-83S